Gene-editing Diagnostics Co. SeQure Dx Announces $17.5M Funding
Patented technology addresses emerging need for personalized diagnostics that assess the risks of gene-editing therapies SeQure Dx, a gene-editing diagnostics company, announced today a $17.5...